Search

1. The role of community health centers in addressing the opioid epidemic

Author(s):

Zur, Julia, author
Tolbert, Jennifer, author
Sharac, Jessica, author
Markus, Anne, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, July 2018

Subject(s):

Community Health Centers -- statistics & numerical data
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- prevention & control
United States

2. The opium and whisky habits, and their cure

Author(s):

Woolley, B. M. (Basil M.), 1834- author

Publication:

Atlanta, Ga. : Constitution Job Office, [1889?]

Subject(s):

Opioid-Related Disorders -- drug therapy
Alcohol-Related Disorders -- drug therapy
Nostrums

3. The opium habit: its successful treatment by the Avena sativa : a paper read before the New York State Medical Society, February 9th, 1882, with additions, giving a fuller description of its therapeutic action in different diseases, etc

Author(s):

Sell, E. H. M. (Edward Herman Miller), 1832-1920 author

Publication:

Jersey City : The Evening journal print, 1883

Subject(s):

Opioid-Related Disorders -- drug therapy
Phytotherapy
Avena

4. Management of patients with opioid dependence: a review of clinical, delivery system, and policy options

Publication:

[Boston, MA] : Institute for Clinical and Economic Review, July 2014

Subject(s):

Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Delivery of Health Care
Health Policy
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Opiate Substitution Treatment -- economics
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- rehabilitation
New England
United States

5. Primary care: on the front lines of the opioid epidemic

Author(s):

Bachhuber, Marcus A., author
Weiner, Janet, author
Mitchell, Julia, author
Samet, Jeffrey, author

Publication:

Philadelphia, PA : Leonard Davis Institute of Health Economics, August 2016

Subject(s):

Opioid-Related Disorders -- diagnosis
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- epidemiology
Primary Health Care
United States

6. Show me the money: economic evaluations of opioid use disorder interventions

Author(s):

Murphy, Sean M., author
Polsky, Daniel, author
Meisel, Zachary, author
Mitchell, Julia, author

Publication:

Philadelphia, PA : Leonard Davis Institute of Health Economics, May 2016

Subject(s):

Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
United States

7. Opioid use decreased in Medicare Part D, while medication-assisted treatment increased

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019

Subject(s):

Analgesics, Opioid -- therapeutic use
Medicare Part D
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

8. Telehealth MAT

Publication:

[Oakland, California] : California Health Care Foundation, June 2019

Subject(s):

Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Telemedicine
California
United States

9. MAT in the emergency department: FAQ

Author(s):

Newman, Sandra, author

Publication:

[Oakland, California] : California Health Care Foundation, March 2019

Subject(s):

Emergency Medical Services
Emergency Service, Hospital
Insurance, Health, Reimbursement
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Substance-Related Disorders -- drug therapy
California
United States

10. MAT for opioid use disorder: overcoming objections

Author(s):

Strugar-Fritsch, Donna, author

Publication:

[Oakland, California] : California Health Care Foundation, August 2019

Subject(s):

Buprenorphine -- therapeutic use
Health Knowledge, Attitudes, Practice
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
California
United States

11. MAT for hospitalized patients

Author(s):

Newman, Sandra, author

Publication:

[Oakland, California] : California Health Care Foundation, June 2019

Subject(s):

Hospitalization
Inpatients
Insurance, Health, Reimbursement
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
California
United States

12. Buprenorphine: an overview for clinicians

Author(s):

Steiger, Scott, author
DeFries, Triveni, author

Publication:

[Oakland, California] : California Health Care Foundation, August 2019

Subject(s):

Buprenorphine -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
California
United States

13. How community health centers are addressing the opioid epidemic: case study

Author(s):

Hayes, Robert M., author
Squitieri, Joseph, author

Publication:

New York, NY : Milbank Memorial Fund, April 2019

Subject(s):

Child of Impaired Parents
Community Health Centers
Community Health Services
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

14. Opioid use disorder: developing depot buprenorphine products for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, February 2019

Subject(s):

Buprenorphine -- therapeutic use
Drug Development
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

15. Opioid use disorder: endpoints for demonstrating effectiveness of drugs for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, October 2020

Subject(s):

Analgesics, Opioid
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

16. Study finds increased use of medications for OUD among Medicaid enrollees in 11 states

Publication:

Washington, DC : AcademyHealth, July 2021

Subject(s):

Medicaid -- statistics & numerical data
Opiate Substitution Treatment -- statistics & numerical data
Opioid-Related Disorders -- drug therapy
United States

17. Lowering the barriers to medication treatment for people with opioid use disorder: evidence for a low-threshold approach

Author(s):

Aronowitz, Shoshana V., author
Behrends, Czarina Navos, author
Lowenstein, Margaret, author
Schackman, Bruce, author
Weiner, Janet, author

Publication:

Philadelphia, PA : Leonard Davis Institute of Health Economics, January 2022

Subject(s):

Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Health Services Accessibility
United States

18. Increasing access to medications for opioid use disorder: policy strategies during and after COVID-19 pandemic

Author(s):

Au-Yeung, Caroline M., author
Blewett, Lynn A., author
Winkelman, Tyler N.A., author

Publication:

New York, NY : Milbank Memorial Fund, October 2021

Subject(s):

Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
COVID-19
Health Policy
Methadone -- therapeutic use
Naltrexone -- therapeutic use
United States

19. Opioid use disorder: barriers to Medicaid beneficiaries' access to treatment medications : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, January 2020

Subject(s):

Analgesics, Opioid -- supply & distribution
Analgesics, Opioid -- therapeutic use
Health Services Accessibility
Medicaid -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
Centers for Medicare & Medicaid Services (U.S.)

20. Geographic disparities affect access to buprenorphine services for opioid use disorder

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, January 2020

Subject(s):

Buprenorphine -- supply & distribution
Health Services Accessibility
Medically Underserved Area
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Substance Abuse and Mental Health Services Administration

21. The risk of misuse and diversion of buprenorphine for opioid use disorder appears to be low in Medicare Part D

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2023

Subject(s):

Buprenorphine
Buprenorphine, Naloxone Drug Combination
Government Regulation
Medicare Part D
Opioid-Related Disorders -- drug therapy
United States

22. Catalyzing Medicaid policy research with T-MSIS Analytic Files (TAF): learnings from year 1 of the Medicaid Data Learning Network (MDLN)

Author(s):

Gordon, Sarah, (Of Boston University), author
Johnson, Annaliese, author
Kennedy, Susan, (Of AcademyHealth), author
McConnel, John, (Of Oregon Health & Science University), author
Schpero, William, author

Publication:

Washington, DC : AcademyHealth, May 15, 2023

Subject(s):

Datasets as Topic
Health Policy
Health Services Research
Medicaid -- statistics & numerical data
Ethnicity
Fee-for-Service Plans
Health Expenditures
Information Storage and Retrieval
Managed Care Programs
Maternal Health
Opioid-Related Disorders -- drug therapy
Racial Groups
Reproductive Health
Utilization Review
United States

23. The risk of misuse and diversion of buprenorphine for opioid use disorder in Medicare Part D continues to appear low: 2022

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023

Subject(s):

Buprenorphine
Drug Users -- statistics & numerical data
Government Regulation
Medicare Part D -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Prescription Drug Diversion -- statistics & numerical data
United States

24. Learning from COVID-19: how pandemic-era policies for methadone prescribing could improve opioid treatment

Author(s):

Suen, Leslie W., author
Nguyen, Oanh K., author
Knight, Kelly Ray, 1969- author

Publication:

[Oakland, California] : California Health Care Foundation, April 2022

Subject(s):

COVID-19
Methadone -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Prescriptions
Health Policy
California

25. Expanding access to naloxone: a review of distribution strategies

Author(s):

Weiner, Janet, author
Murphy, Sean, author
Behrends, Czarina, author

Publication:

Philadelphia, PA : Leonard Davis Institute of Health Economics, May 2019

Subject(s):

Drug Overdose -- drug therapy
Drug Overdose -- prevention & control
Health Services Accessibility
Naloxone -- supply & distribution
Naloxone -- therapeutic use
Opioid-Related Disorders -- drug therapy
United States

26. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 3, 2018

Subject(s):

Analgesics, Opioid -- therapeutic use
Narcotic Antagonists -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

27. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate

Publication:

Washington, DC : United States Government Accountability Office, October 2017

Subject(s):

Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Outcome Assessment, Health Care
United States
United States. Department of Health and Human Services

28. Why health plans should go to the "MAT" in the fight against opioid addiction

Author(s):

Elitzer, Julia, author
Tatar, Margaret, author

Publication:

[Oakland, Calif.] : California Health Care Foundation, September 2017

Subject(s):

Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- prevention & control
California
United States

29. The opium habit: its successful treatment by the Avena sativa, a paper read before the New York State Medical Society, February 9, 1882

Author(s):

Sell, E. H. M. (Edward Herman Miller), 1832-1920 author

Publication:

Jersey City : Evening Journal Print, 1882

Subject(s):

Opioid-Related Disorders -- drug therapy
Avena
Plant Extracts -- therapeutic use

30. Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS Buprenorphine Practice Guidelines

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 2, 2022

Subject(s):

Buprenorphine -- therapeutic use
Drug Prescriptions -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Opioid-Related Disorders -- drug therapy
Practice Guidelines as Topic
Scope of Practice
United States
United States. Department of Health and Human Services

31. Medical profession endorse Manine in the treatment of morphinism or the drug "habit" disease

Publication:

St. Louis, Mo. : The Manine Medicine Company, [1913?]

Subject(s):

Opioid-Related Disorders -- drug therapy
Nonprescription Drugs

32. Dear Doctor, I wish to call your attention to our remedy, Manine, for the treatment and cure of that diseased condition of the nervous system caused by the use of morphine, laudanum, heroin or opium in any of its forms

Author(s):

Manine Medicine Company, author.

Publication:

St. Louis, Missouri : Manine Medicine Company, [1913?]

Subject(s):

Opioid-Related Disorders -- drug therapy
Nonprescription Drugs

33. The opium habit and its cure, and what others say of his cures

Author(s):

Woolley, B. M. (Basil M.), 1834-

Publication:

[Atlanta?] : Atlanta Constitution Print., [1879?]

Subject(s):

Opioid-Related Disorders -- drug therapy
Nostrums

34. Substitution: Damit hab ich HIV

Publication:

[Berlin] : Deutsche AIDS-Hilfe, 2011

Subject(s):

HIV Infections -- prevention & control
Acquired Immunodeficiency Syndrome -- prevention & control
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy

35. Substitution: Meine Chance für Ausbildung und Beruf

Publication:

[Berlin] : Deutsche AIDS-Hilfe, 2011

Subject(s):

Opioid-Related Disorders -- drug therapy
Acquired Immunodeficiency Syndrome -- prevention & control
HIV Infections -- prevention & control
Opiate Substitution Treatment

36. Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023

Subject(s):

Ethnic and Racial Minorities -- statistics & numerical data
Government Regulation
Health Inequities
Healthcare Disparities
Medicaid
Morphinans -- supply & distribution
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

37. The consistently low percentage of Medicare enrollees receiving medication to treat their opioid use disorder remains a concern

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2023

Subject(s):

Government Regulation
Medicare
Opiate Overdose -- prevention & control
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

38. MAT in community health centers

Author(s):

Newman, Sandra, author
Fisher, Tammy, author

Publication:

[Oakland, Calif.] : California Health Care Foundation, January 2019

Subject(s):

Community Health Centers -- economics
Insurance, Health, Reimbursement
Opiate Substitution Treatment -- economics
Opioid-Related Disorders -- drug therapy
Reimbursement Mechanisms
California
United States

39. The opium habit

Publication:

[Iowa?] : [publisher not identified], [1889?]

Subject(s):

Opioid-Related Disorders -- drug therapy